• | home
  • | corporate
  • | investors
  • | products
  • | clinical trials
  • | partnering
  • | contact
TSX: HBP - NYSE Amex: HBP - Frankfurt: HBP

  • | Topical Interferon Alpha-2b
  • | L-DOS47

Topical Interferon Alpha-2b

 

Indication Study ID Title Status   
Ano-genital warts IFN001 Treatment of genital warts with Interferon alpha-2b Cream: a randomized, double blind, placebo-controlled study Completed Details
Cervical Dysplasia (CIN I or II) IFN005 Multiple-Dose Pharmacokinetic, Efficacy and Safety Study of Interferon alpha-2b in Women with a History of Cytological diagnosis Pap IIID, with a confirmed histological diagnosis of CIN I or II, and of confirmed HPV Positive Status: a mono-centre, open-label study Completed Details


  • | home
  • | site map
  • | privacy
  • | terms of use / disclaimers
  • | polski
  • | login
© Helix BioPharma Corp.